Clarivate believes non-GAAP results are useful ... In life science, we launched DRG Fusion, a new modular subscription-based real-world data analytics product. This will shift focus from ...

Clarivate Plc (NYSE:CLVT ... In life science, we launched DRG Fusion, a new modular subscription-based real-world data analytics product. This will shift focus from transactional data brokering ...

1 Sources: Medical Insight, Inc.: The Global Aesthetic Market Study—January 2024 (US), Clarivate | DRG: Aesthetic Injectables Market Insights North America 2024—October 2023 (Canada), Clarivate | DRG: ...

Handelsbanken Fonder AB lowered its stake in Clarivate Plc (NYSE:CLVT – Free Report) by 7.4% in the 4th quarter, HoldingsChannel.com reports. The firm owned 105,700 shares of the company’s ...

Clarivate PLC (CLVT) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.23 per share a year ago.

Clarivate PLC (CLVT) reported its fourth-quarter results for 2024, showcasing a slight earnings beat with an adjusted diluted EPS of $0.21, surpassing the forecasted $0.20. Despite this, the company's ...

LONDON, Feb. 27, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) a leading global provider of transformative intelligence, has released a new white paper, How is Latin America Growing?, shedding light ...

LONDON, Feb. 18, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a new subscription-based content access strategy.

(1) Reflects restructuring costs expected to be incurred in 2025 associated with the Value Creation Plan. (2) For the purposes of calculating adjusted diluted EPS, we have assumed the "if ...

Clarivate PLC (NYSE:CLVT), a global leader in providing trusted insights and analytics with a market capitalization of $3.14 billion, is navigating through a period of significant transition. The ...